Hansen, P R <br/><br/>
Freunds adjuvant alone is antiatherogenic in apoE-deficient mice and specific immunization against TNFalpha confers no additional benefit.  [electronic resource] 

 -  Atherosclerosis  Sep 2001 
 - 87-94 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0021-9150 
<br/><br/><label>Standard No.: </label>10.1016/s0021-9150(01)00418-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibody Formation<br/>Aorta--pathology<br/>Apolipoproteins E--deficiency<br/>Arteriosclerosis--immunology<br/>Body Weight<br/>Chaperonin 60--immunology<br/>Disease Susceptibility<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Freund's Adjuvant--immunology<br/>Immunization<br/>Lipids--blood<br/>Malondialdehyde--immunology<br/>Mice<br/>Mice, Inbred C57BL<br/>Recombinant Proteins--immunology<br/>Tumor Necrosis Factor-alpha--immunology